文献
J-GLOBAL ID:202202215429395176
整理番号:22A0808408
腫瘍組織におけるクローン的に拡大したTreg細胞のCCR8標的特異的枯渇は長期持続性記憶を有する強力な腫瘍免疫を引き起こす【JST・京大機械翻訳】
CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory
著者 (56件):
Kidani Yujiro
(Department of Basic Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Kidani Yujiro
(Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, 565-0871 Osaka, Japan)
,
Kidani Yujiro
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Nogami Wataru
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Yasumizu Yoshiaki
(Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, 565-0871 Osaka, Japan)
,
Kawashima Atsunari
(Department of Urology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Kawashima Atsunari
(Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Tanaka Atsushi
(Department of Basic Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Tanaka Atsushi
(Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, 565-0871 Osaka, Japan)
,
Sonoda Yudai
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Tona Yumi
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Nashiki Kunitaka
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Matsumoto Reimi
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Hagiwara Masaki
(Department of Basic Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Hagiwara Masaki
(Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, 565-0871 Osaka, Japan)
,
Hagiwara Masaki
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Osaki Motonao
(Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, 565-0871 Osaka, Japan)
,
Dohi Keiji
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Kanazawa Takayuki
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Kanazawa Takayuki
(Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Ueyama Azumi
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Ueyama Azumi
(Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Yoshikawa Mai
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Yoshida Tetsuya
(Department of Basic Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Yoshida Tetsuya
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Matsumoto Mitsunobu
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Matsumoto Mitsunobu
(Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Hojo Kanji
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Shinonome Satomi
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Yoshida Hiroshi
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Hirata Michinari
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Hirata Michinari
(Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Haruna Miya
(Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan)
,
Haruna Miya
(Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Nakamura Yamami
(Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, 565-0871 Osaka, Japan)
,
Motooka Daisuke
(Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, 565-0871 Osaka, Japan)
,
Okuzaki Daisuke
(Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, 565-0871 Osaka, Japan)
,
Sugiyama Yasuko
(Department of Neurology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Kinoshita Makoto
(Department of Neurology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Okuno Tatsusada
(Department of Neurology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Kato Taigo
(Department of Urology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Hatano Koji
(Department of Urology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Uemura Motohide
(Department of Urology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Imamura Ryoichi
(Department of Urology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Yokoi Kazunori
(Department of Dermatology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Tanemura Atsushi
(Department of Dermatology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Shintani Yasushi
(Department of General Thoracic Surgery, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Kimura Tadashi
(Department of Obstetrics and Gynecology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Nonomura Norio
(Department of Urology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Wada Hisashi
(Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Wada Hisashi
(Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Mori Masaki
(Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Doki Yuichiro
(Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Ohkura Naganari
(Department of Basic Research in Tumor Immunology, Graduate School of Medicine, Osaka University, 565-0871 Osaka, Japan)
,
Ohkura Naganari
(Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, 565-0871 Osaka, Japan)
,
Sakaguchi Shimon
(Department of Experimental Immunology, Immunology Frontier Research Center, Osaka University, 565-0871 Osaka, Japan)
資料名:
Proceedings of the National Academy of Sciences of the United States of America
(Proceedings of the National Academy of Sciences of the United States of America)
巻:
119
号:
7
ページ:
e2114282119
発行年:
2022年
JST資料番号:
D0387A
ISSN:
0027-8424
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)